APLT: Applied Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 578.06
Enterprise Value ($M) 528.48
Book Value ($M) -17.15
Book Value / Share -0.15
Price / Book -33.71
NCAV ($M) -17.59
NCAV / Share -0.15
Price / NCAV -32.86

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.99
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.76
Current Ratio 0.76

Balance Sheet (mrq) ($M)
Current Assets 54.39
Assets 54.83
Liabilities 71.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.99
Operating Income -64.53
Net Income -119.76
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -55.17
Cash from Investing 13.87
Cash from Financing 74.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-08 13G Janus Henderson Group Plc 6.10
03-05 13D/A Shendelman Shoshana 8.20 7.00
02-22 13G/A Propel Bio Management, LLC 10.50 69.66
02-14 13G/A Alyeska Investment Group, L.P. 9.99 60.57
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 9.99 35.88
02-14 13G/A Orbimed Advisors Llc 0.00 -100.00
02-14 13G/A Armistice Capital, Llc 0.00 -100.00
02-14 13G/A Alexandria Real Estate Equities, Inc. 15.40 -4.28
02-14 13G/A Perceptive Advisors Llc 5.90 0.00
02-13 13G Vestal Point Capital, LP 5.40
02-09 13G/A Fmr Llc 3.14 -18.33
02-06 13G/A Franklin Resources Inc 9.99 -0.98
2023-03-31 13G/A Propel Bio Partners L.P. 2.57 -50.73

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-16 124,322 465,126 26.73
2024-04-15 216,690 1,098,609 19.72
2024-04-12 129,773 235,498 55.11
2024-04-11 77,216 268,650 28.74

(click for more detail)

Similar Companies
ALT – Altimmune, Inc. ANIP – ANI Pharmaceuticals, Inc.
APGE – Apogee Therapeutics, Inc. AQST – Aquestive Therapeutics, Inc.
ARCT – Arcturus Therapeutics Holdings Inc.


Financial data and stock pages provided by
Fintel.io